Quick Answer
GYRE THERAPEUTICS, INC. reported Shares Outstanding of 91.31 million shares for fiscal year 2025.
GYRE THERAPEUTICS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 91.31M | +5.8% |
| 2024 | 86.31M | +12.7% |
| 2023 | 76.60M | +20.5% |
| 2022 | 63.59M | +102.4% |
| 2021 | 31.41M | +42.1% |
| 2020 | 22.10M | +83.5% |
| 2019 | 12.04M | +0.7% |
| 2018 | 11.95M | +96.6% |
| 2017 | 6.08M | +658.5% |
| 2016 | 801,756 | +5.2% |
| 2015 | 762,005 | +105.4% |
| 2014 | 370,944 | -98.9% |
| 2013 | 33.72M | +0.3% |
| 2012 | 33.62M | +0.7% |
| 2011 | 33.38M | +15.6% |
| 2010 | 28.87M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 90.89M | +6.0% | +0.1% |
| June 30, 2025 | 90.82M | +6.2% | +3.6% |
| March 31, 2025 | 87.64M | +2.6% | +1.5% |
| December 31, 2024 | 86.31M | +12.7% | +0.6% |
| September 30, 2024 | 85.77M | +125.8% | +0.3% |
| June 30, 2024 | 85.54M | +125.2% | +0.1% |
| March 31, 2024 | 85.42M | +126.2% | +11.5% |
| December 31, 2023 | 76.60M | +102.9% | +101.7% |
- GYRE THERAPEUTICS, INC. showed an increase of +5.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, GYRE THERAPEUTICS, INC.’s shares outstanding has grown by 216.3% (from 28.87 million shares to 91.31 million shares).
- The most recent figure is from GYRE THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: